Insulet granted EU-wide injunction against EOFlow in default decision by UPC
MLex Summary: Insulet Corporation has won a injunction against EOFlow from the Unified Patent Court over its EP 4,201,327 used in insulin pumps. The Milan Central Division found that EOFlow’s EOPatch...To view the full article, register now.
Already a subscriber? Click here to view full article